Improving early cancer detection and treatment in Botswana
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation
This study is all about helping people in Botswana find and treat cancer earlier, especially those living with HIV, by encouraging them to see a doctor sooner when they notice symptoms, and it will involve working with several rural communities to make sure everyone gets the care they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10696252 on NIH RePORTER |
What this research studies
This research focuses on enhancing the early detection and treatment of cancer in Botswana, particularly in the context of the HIV pandemic. It aims to implement a community-based intervention that encourages individuals to seek medical attention sooner when experiencing cancer symptoms. The study will involve multiple rural communities and will assess the effectiveness of strategies designed to improve diagnosis and treatment initiation for cancer patients. By leveraging existing healthcare resources in Botswana, the research seeks to bridge gaps in timely cancer care.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults living in Botswana who may be experiencing symptoms suggestive of cancer.
Not a fit: Patients who are not residents of Botswana or those who do not exhibit symptoms of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier cancer diagnoses and improved treatment outcomes for patients in Botswana.
How similar studies have performed: Previous pilot trials in Botswana have shown success in increasing patient engagement in cancer care through similar community-based interventions.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Dryden-Peterson, Scott — Brigham and Women's Hospital
- Study coordinator: Dryden-Peterson, Scott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.